A Rollover Study for Patients Who Participated in Other Romidepsin Protocols
Status:
Completed
Trial end date:
2012-09-05
Target enrollment:
Participant gender:
Summary
This study is intended to provide access to Romidepsin for participants who received
Romidepsin in other trials sponsored by Gloucester Pharmaceuticals or Celgene Corporation and
for participants whom the investigator feels may benefit from continuing treatment with
Romidepsin.